These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 3613658

  • 21. Thalidomide responsiveness in an infant with Behçet's syndrome.
    Shek LP, Lee YS, Lee BW, Lehman TJ.
    Pediatrics; 1999 Jun; 103(6 Pt 1):1295-7. PubMed ID: 10353947
    [Abstract] [Full Text] [Related]

  • 22. Thalidomide--effect on T cell subsets as a possible mechanism of action.
    Moncada B, Baranda ML, González-Amaro R, Urbina R, Loredo CE.
    Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):201-5. PubMed ID: 3874920
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Behçet's disease].
    Chiheb S, Chakib A, Lakhdar H.
    Ann Dermatol Venereol; 2003 Jun; 130(6-7):657-63. PubMed ID: 13679709
    [No Abstract] [Full Text] [Related]

  • 26. [Speculative ameloriation of arthritis in Behcet disease with thalidomide. A case report].
    Trèves R, Arnaud M, Jacob P, Lubeau M, Tabaraud F, Burki F, Desproges-Gotteron R.
    Rev Rhum Mal Osteoartic; 1984 Nov; 51(10):585. PubMed ID: 6533773
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Thalidomide therapy for juvenile-onset entero-Behçet disease.
    Yasui K, Misawa Y, Shimizu T, Komiyama A, Kawakami T, Mizoguchi M.
    J Pediatr; 2003 Nov; 143(5):692-4. PubMed ID: 14649666
    [No Abstract] [Full Text] [Related]

  • 29. The management of Behçet's syndrome: how are we doing?
    Yazici H, Yurdakul S, Hamuryudan V.
    Clin Exp Rheumatol; 1999 Nov; 17(2):145-7. PubMed ID: 10342039
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Successful treatment by thalidomide therapy of intestinal Behçet's disease associated with trisomy 8 myelodysplastic syndrome.
    Wei Q, Zhang X, Peng Y, Chen K, Xu S, Huang X, Zhang L, Xie Q, He Y, Li Y, Chai J.
    Rheumatology (Oxford); 2021 Jun 18; 60(6):e200-e202. PubMed ID: 33331901
    [No Abstract] [Full Text] [Related]

  • 34. Surgical treatment of Budd-Chiari syndrome induced by Behcet's disease.
    Kuniyoshi Y, Koja K, Miyagi K, Uezu T, Yamashiro S, Arakaki K, Mabuni K, Senaha S.
    Ann Thorac Cardiovasc Surg; 2002 Dec 18; 8(6):374-80. PubMed ID: 12517299
    [Abstract] [Full Text] [Related]

  • 35. Antitumor necrosis factor-alpha therapy for early postoperative recurrence of gastrointestinal Behçet's disease: report of a case.
    Byeon JS, Choi EK, Heo NY, Hong SC, Myung SJ, Yang SK, Kim JH, Song JK, Yoo B, Yu CS.
    Dis Colon Rectum; 2007 May 18; 50(5):672-6. PubMed ID: 17216141
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Thalidomide use.
    Am Fam Physician; 1983 Dec 18; 28(6):237. PubMed ID: 6650339
    [No Abstract] [Full Text] [Related]

  • 38. [An analysis of adverse drug reactions of thalidomide in treatment of immune-related bowel diseases].
    Luo HQ, Tan B, Lü H, Qian JM.
    Zhonghua Nei Ke Za Zhi; 2013 Sep 18; 52(9):726-9. PubMed ID: 24314159
    [Abstract] [Full Text] [Related]

  • 39. [Thalidomide--a possible alternative as an immunomodulating agent].
    Lakartidningen; 1989 Nov 29; 86(48):4260-2. PubMed ID: 2593763
    [No Abstract] [Full Text] [Related]

  • 40. Behçet's syndrome: treatment with chlorambucil.
    Elliott JH, Ballinger WH.
    Trans Am Ophthalmol Soc; 1984 Nov 29; 82():264-81. PubMed ID: 6535326
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.